NANO Nuclear Energy Inc. announced its second fiscal quarter results for the period ended March 31, 2025, on May 16, 2025. The company reported a net loss of $24.42 million for the six months ended March 31, 2025, a significant increase from $2.99 million in the same period of 2024. This increase in losses reflects accelerated research and development activities and higher general and administrative expenses.
Despite the increased operating losses and negative cash flow from operations of $5.62 million for the six months, NANO Nuclear maintained a strong liquidity position. As of March 31, 2025, the company held $118.55 million in cash and cash equivalents and $115.08 million in working capital. This robust financial standing was bolstered by approximately $14.40 million from warrant exercises, $1.60 million from stock option exercises, and $92.30 million from public and private equity offerings during the six months ended March 31, 2025.
Operational highlights for the quarter included the finalization of the KRONOS MMR™ and LOKI MMR™ microreactor acquisitions, solidifying relationships with the University of Illinois Urbana-Champaign for KRONOS MMR construction, and receiving NRC approval for the KRONOS MMR fuel qualification methodology. The company also committed to a new demonstration facility in Westchester County, New York, and expanded its technical and regulatory teams, including the appointment of Dr. Florent Heidet as CTO.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.